Key statistics
On Monday, Adlai Nortye Ltd (N2U0:STU) closed at 6.40, -41.82% below its 52-week high of 11.00, set on Jan 30, 2026.
52-week range
| Open | 6.70 |
|---|---|
| High | 6.85 |
| Low | 6.00 |
| Bid | 6.50 |
| Offer | 7.85 |
| Previous close | 7.00 |
| Average volume | 50.20 |
|---|---|
| Shares outstanding | 58.44m |
| Free float | 49.36m |
| P/E (TTM) | -- |
| Market cap | 459.33m USD |
| EPS (TTM) | -1.14 USD |
Data delayed at least 15 minutes, as of Mar 02 2026.
More ▼
Announcements
- Adlai Nortye Announces First Patient Enrolled in Global Phase 1 Trial of Pan-RAS (ON) Inhibitor AN9025 for Solid Tumors Harboring RAS Mutations
- Adlai Nortye Announces $140.0 Million Private Placement Equity Financing
- Adlai Nortye Enters Exclusive License Agreement with ASK Pharm for Pan-RAS (ON) Inhibitor AN9025 in Greater China
- Adlai Nortye to Participate in Upcoming Investor Conferences
- Adlai Nortye to Present Short Talk on AN4035 Preclinical Results at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
- Adlai Nortye to Present Short Talk at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
- Adlai Nortye to Present Research Findings at AACR Annual Meeting 2025
More ▼
